These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19057622)

  • 1. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.
    Delgado M; Anderson P; Garcia-Salcedo JA; Caro M; Gonzalez-Rey E
    Cell Death Differ; 2009 Mar; 16(3):406-16. PubMed ID: 19057622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
    Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
    Hofer A; Steverding D; Chabes A; Brun R; Thelander L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma brucei: effects of methoprene and other isoprenoid compounds on procyclic and bloodstream forms in vitro and in mice.
    Harmon MA; Scott TC; Li Y; Boehm MF; Phillips MA; Mangelsdorf DJ
    Exp Parasitol; 1997 Nov; 87(3):229-36. PubMed ID: 9371088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of toxic compounds to the trypanosome's interior.
    Barrett MP; Gilbert IH
    Adv Parasitol; 2006; 63():125-83. PubMed ID: 17134653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
    Smith TK; Crossman A; Brimacombe JS; Ferguson MA
    EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human resistance to African trypanosoma infections].
    Perez-Morga D
    Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.
    Kubata BK; Nagamune K; Murakami N; Merkel P; Kabututu Z; Martin SK; Kalulu TM; Huq M; Yoshida M; Ohnishi-Kameyama M; Kinoshita T; Duszenko M; Urade Y
    Int J Parasitol; 2005 Jan; 35(1):91-103. PubMed ID: 15619520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo trypanocidal activity of Annona senegalensis Pers. leaf extract against Trypanosoma brucei brucei.
    Ogbadoyi EO; Abdulganiy AO; Adama TZ; Okogun JI
    J Ethnopharmacol; 2007 May; 112(1):85-9. PubMed ID: 17418511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
    Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
    Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and neuropeptides at the crossroad for parasites: to survive or to die?
    Campos-Salinas J; Gonzalez-Rey E
    Autophagy; 2009 May; 5(4):551-4. PubMed ID: 19337024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs and drug resistance in African trypanosomiasis.
    Delespaux V; de Koning HP
    Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semicarbazide-sensitive amine oxidase kills African trypanosomes in vitro.
    Wang QP; Lai DH; Li Z; Li FJ; Lun ZR
    Acta Trop; 2011 Feb; 117(2):161-4. PubMed ID: 21145304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African trypanosomes: intracellular trafficking of host defense molecules.
    Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
    J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.